{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T14:45:13Z","timestamp":1770734713656,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.vaccine.2012.09.008","type":"journal-article","created":{"date-parts":[[2012,9,16]],"date-time":"2012-09-16T11:00:28Z","timestamp":1347793228000},"page":"6859-6863","source":"Crossref","is-referenced-by-count":21,"title":["Conducting vaccine clinical trials in sub-Saharan Africa: Operational challenges and lessons learned from the Meningitis Vaccine Project"],"prefix":"10.1016","volume":"30","author":[{"given":"Elisa","family":"Marchetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Mazarin-Diop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Chaumont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Martellet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Fran\u00e7oise","family":"Makadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta","family":"Viviani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasad S.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Pierre","family":"Preziosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.09.008_bib0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Manson Lecture. Meningococcal meningitis in Africa","volume":"93","author":"Greenwood","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.09.008_bib0010","first-page":"3","article-title":"La m\u00e9ningite c\u00e9r\u00e9brospinale en Afrique","volume":"28","author":"Lapeyssonnie","year":"1963","journal-title":"Bull World Health Organ"},{"issue":"9580","key":"10.1016\/j.vaccine.2012.09.008_bib0015","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","article-title":"Epidemic meningitis, meningococcaemia, and Neisseria meningitidis","volume":"369","author":"Stephens","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.09.008_bib0020","doi-asserted-by":"crossref","first-page":"A97","DOI":"10.1016\/j.vaccine.2007.04.049","article-title":"The Meningitis Vaccine Project","volume":"25S","author":"LaForce","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.008_bib0025","unstructured":"http:\/\/www.meningvax.org\/."},{"key":"10.1016\/j.vaccine.2012.09.008_bib0030","doi-asserted-by":"crossref","first-page":"B13","DOI":"10.1016\/j.vaccine.2009.04.062","article-title":"Epidemic meningitis due to group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution","volume":"27S","author":"LaForce","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2012.09.008_bib0035","doi-asserted-by":"crossref","DOI":"10.1377\/hlthaff.2011.0328","article-title":"Eliminating epidemic group A Meningococcal Meningitis in Africa through a new vaccine","volume":"30","author":"LaForce","year":"2011","journal-title":"Health Aff"},{"key":"10.1016\/j.vaccine.2012.09.008_bib0040","doi-asserted-by":"crossref","first-page":"A101","DOI":"10.1016\/j.vaccine.2007.04.050","article-title":"Safety, immunogenicity and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults","volume":"26S","author":"Kshirsagar","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.008_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2012.08.004","article-title":"Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2\u201310 years: a 2 phase II\/III double-blind randomized controlled trial","author":"Hirve","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.008_bib0050","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1003812","article-title":"Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans","volume":"364","author":"Sow","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.09.008_bib0055","unstructured":"ICH Harmonised Tripartite Guideline for Good Clinical Practice E6(R1), Current step 4 version dated 10 June 1996."},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.09.008_bib0060","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(07)70288-8","article-title":"Meningococcal carriage in the African meningitis belt","volume":"7","author":"Trotter","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"April (Suppl. 2)","key":"10.1016\/j.vaccine.2012.09.008_bib0065","doi-asserted-by":"crossref","first-page":"B40","DOI":"10.1016\/j.vaccine.2011.12.073","article-title":"Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience","volume":"30","author":"Djingarey","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.008_bib0070","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1016\/j.vaccine.2009.08.113","article-title":"Regulatory oversight of clinical trials in Africa: Progress over the past 5 years","volume":"27","author":"Ma\u00efga","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.008_bib0075","doi-asserted-by":"crossref","unstructured":"Ma\u00efga D, Akanmori BD, Chocarro L. Joint reviews and inspections: Strategic forms of collaboration for strengthening the regulatory oversight of vaccine clinical trials in Africa. Vaccine 2010; 28: 571\u2013575.","DOI":"10.1016\/j.vaccine.2009.09.117"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12013072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12013072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T13:58:16Z","timestamp":1542722296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12013072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":15,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0264410X12013072"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.09.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}